Literature DB >> 10742559

Antigen-specific T cell trafficking into the central nervous system.

Z Qing1, D Sewell, M Sandor, Z Fabry.   

Abstract

The initiation step of cell-mediated immune responses in the central nervous system (CNS) involves the trafficking of the antigen-specific T cells into the brain. To study this trafficking, we developed an in vivo system for studying antigen-specific responses in the CNS. In this assay, T cell receptor (TCR) transgenic mice having 95% of T cells specific for a defined antigen-pigeon cytochrome c (PCC) were cannulated intraventricularly for PCC antigen infusion and cerebrospinal fluid (CSF) sampling. Upon PCC infusion into the CNS, the number of alpha/beta TCR(+) Vbeta3(+) Mac1(-) cells in the CSF was characterized. We found that infusion of antigen into the CSF induced an increased number of antigen-specific T cells in the CNS and activation of antigen-specific T cells in the peripheral blood. Hence, the drainage of CNS antigen into the periphery might play an important role in sustaining autoimmune reactivity in CNS inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10742559     DOI: 10.1016/s0165-5728(99)00265-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

Review 1.  Rett syndrome and other autism spectrum disorders--brain diseases of immune malfunction?

Authors:  N C Derecki; E Privman; J Kipnis
Journal:  Mol Psychiatry       Date:  2010-02-23       Impact factor: 15.992

2.  In situ activation of antigen-specific CD8+ T cells in the presence of antigen in organotypic brain slices.

Authors:  Changying Ling; Yakov I Verbny; Matthew I Banks; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

3.  Regional Distribution of CNS Antigens Differentially Determines T-Cell Mediated Neuroinflammation in a CX3CR1-Dependent Manner.

Authors:  Aditya Rayasam; Julie A Kijak; McKenna Dallmann; Martin Hsu; Nicole Zindl; Anders Lindstedt; Leah Steinmetz; Jeffrey S Harding; Melissa G Harris; Jozsef Karman; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Neurosci       Date:  2018-06-29       Impact factor: 6.167

4.  DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation.

Authors:  Doris Lambracht-Washington; Bao-Xi Qu; Min Fu; Larry D Anderson; Olaf Stüve; Todd N Eagar; Roger N Rosenberg
Journal:  Cell Mol Neurobiol       Date:  2011-04-06       Impact factor: 5.046

5.  Age-Associated Resident Memory CD8 T Cells in the Central Nervous System Are Primed To Potentiate Inflammation after Ischemic Brain Injury.

Authors:  Rodney M Ritzel; Joshua Crapser; Anita R Patel; Rajkumer Verma; Jeremy M Grenier; Anjali Chauhan; Evan R Jellison; Louise D McCullough
Journal:  J Immunol       Date:  2016-03-09       Impact factor: 5.422

Review 6.  Current concepts on communication between the central nervous system and peripheral immunity via lymphatics: what roles do lymphatics play in brain and spinal cord disease pathogenesis?

Authors:  Martin Hsu; Matyas Sandor; Zsuzsanna Fabry
Journal:  Biol Futur       Date:  2021-02-01

7.  Regulation of learning and memory by meningeal immunity: a key role for IL-4.

Authors:  Noël C Derecki; Amber N Cardani; Chun Hui Yang; Kayla M Quinnies; Anastasia Crihfield; Kevin R Lynch; Jonathan Kipnis
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

8.  Short-term sPECAM-Fc treatment ameliorates EAE while chronic use hastens onset of symptoms.

Authors:  Emily K Reinke; Jangeun Lee; Alla Zozulya; Jozsef Karman; William A Muller; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Neuroimmunol       Date:  2007-04-27       Impact factor: 3.478

Review 9.  Neuroinflammation-Driven Lymphangiogenesis in CNS Diseases.

Authors:  Martin Hsu; Collin Laaker; Matyas Sandor; Zsuzsanna Fabry
Journal:  Front Cell Neurosci       Date:  2021-06-23       Impact factor: 6.147

10.  Glioma stem cells and immunotherapy for the treatment of malignant gliomas.

Authors:  Masahiro Toda
Journal:  ISRN Oncol       Date:  2013-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.